Cholestyramine (Upsher-Smith Laboratories, Inc.)
Welcome to the PulseAid listing for the Cholestyramine drug offered from Upsher-Smith Laboratories, Inc.. This Bile Acid Sequestrant [EPC],Bile-acid Binding Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Upsher-Smith Laboratories, Inc. |
| NON-PROPRIETARY NAME: | Cholestyramine |
| SUBSTANCE NAME: | CHOLESTYRAMINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Bile Acid Sequestrant [EPC],Bile-acid Binding Activity [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | POWDER, FOR SUSPENSION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2012-01-05 |
| END MARKETING DATE: | 0000-00-00 |
Cholestyramine HUMAN PRESCRIPTION DRUG Details:
| Item Description | Cholestyramine from Upsher-Smith Laboratories, Inc. |
| LABELER NAME: | Upsher-Smith Laboratories, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 4(g/9g) |
| START MARKETING DATE: | 2012-01-05 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0245-0536_8bd7d029-32bc-43fe-b1e1-9c8e28ae880d |
| PRODUCT NDC: | 0245-0536 |
| APPLICATION NUMBER: | ANDA074557 |
Other CHOLESTYRAMINE Pharmaceutical Manufacturers / Labelers:
